Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Khyati Roberts"'
Autor:
Khyati Roberts, Roopal Thakkar, Lina Aljuburi, Donna Boyce, Sean Curtis, Jennifer Dudinak, Helen Fitton, Carlos Garner, Michael Garvin, Susan Longman, Edward Reilly, Jordan Maitland, Alexis Reisin Miller, Muriel Pasté, Michelle Rohrer, Mark Taisey, Karin Van Baelen, Max Wegner
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 6, Pp 1321-1327 (2022)
Externí odkaz:
https://doaj.org/article/101581f4da4943ee986adb99812432af
Autor:
Susan Berger, Robert Kowalski, Michael Garvin, Deborah Autor, Sandra Milligan, Roopal Thakkar, Carlos Garner, Mark Taisey, Mathias Hukkelhoven, Max Wegner, Peter Honig, Lina AlJuburi, Liza O’Dowd, Khyati Roberts, Helen Fitton, Jerry Stewart, Karin Van Baelen, Edward Reilly, Patrick Brady, Andrew S. Robertson
Publikováno v:
Clinical Pharmacology & Therapeutics. 109:1390-1392
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf141f244368d14c909d0ac26449c187
https://doi.org/10.1002/cpt.2046
https://doi.org/10.1002/cpt.2046
Autor:
Mark Taisey, Peter Honig, Carlos Garner, Sharon Olmstead, Andrew S. Robertson, Robert Kowalski, Karin Van Baelen, Michelle Rohrer, Khyati Roberts, Liza O’Dowd, Jerry Stewart, Michael Garvin, Max Wegner, Sandra Milligan, Edward Reilly, Roopal Thakkar, Helen Fitton, Mathias Hukkelhoven, Fabio Bisordi, Deborah Autor
Publikováno v:
Clinical pharmacology and therapeutics. 108(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a40a59f0b7e552ea3978d03599e3675
https://pubmed.ncbi.nlm.nih.gov/32337707
https://pubmed.ncbi.nlm.nih.gov/32337707
Autor:
Max Wegner, Helen Fitton, Robert Kowalski, Peter Honig, Michelle Rohrer, Khyati Roberts, Roopal Thakkar, Mathias Hukkelhoven, Mark Taisey, Hilary Malone, Stacy Holdsworth, Andrew S. Robertson, Sandra Milligan, Carlos Garner, Liza O’Dowd, Jerry Stewart, Karin Van Baelen, Fabio Bisordi
Publikováno v:
Nature Reviews Drug Discovery. 19:365-366
Cloud-based systems for data submitted by sponsors to drug regulatory agencies have the potential to accelerate drug development, streamline regulatory review and enhance regulatory decision-making. Here, we provide a vision for integrating cloud-ena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6eca4e9f9078172d4ade4d94780b51c
https://doi.org/10.1038/d41573-019-00193-7
https://doi.org/10.1038/d41573-019-00193-7